Baranda-Escalona R

Idioma: Español
Referencias bibliográficas: 10
Paginas: 21-22
Archivo PDF: 127.60 Kb.

FRAGMENTO

Cada día decenas de mujeres en México son intervenidas con mastectomías conservadoras o radicales por cáncer de mama. En la actualidad se considera que la inmunosupresión celular por anestésicos y el estrés de la cirugía producen un período perioperatorio vulnerable para el desarrollo de metástasis del tumor.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Tavare AN, Nicholas JS, Perry NJS, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer. 2012;130:1237-1250.

2. Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol. 2012;25:376-384.

3. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105:660-664.

4. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97:1331-1339.

5. Afsharimani B, Cabot PJ, Parat MO. Morphine use in cancer surgery. Front Pharmacol. 2011;2:46. doi:10.3389/fphar.2011.00046

6. Li M, Xiong ZG. Ion channels as targets for cancer therapy. Int J Physiol Pathophysiol Pharmacol. 2011;3:156-166.

7. Brackenbury WJ, Djamgoz MB. Activity-dependent regulation of voltage-gated Na+ channel expression in Mat-LyLu rat prostate cancer cell line. J Physiol. 2006;573:343-356.

8. Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29:477-486.

9. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22:263-277.

10. House CD, Vaske CJ, Schwartz AM, Obias V, Frank B, Luu T, et al. Voltage- gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 2010;70:6957-6967.